- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04065243
Experimental Overfeeding in Humans (ExpO)
Metabolic Changes in Response to Experimental Overfeeding: A Randomized Intervention Study
Study Overview
Status
Intervention / Treatment
Detailed Description
The homeostatic regulation of body weight implies that biological processes have evolved to protect energy stores from changes to the food environment. Accordingly, many individuals remain remarkably weight stable over years without carefully considering how much they eat or how much energy they expend, which has given rise to the theory that body weight is regulated around an individual biological 'set point'. Notably, overfeeding humans in experimentally controlled conditions, support this phenomenon, but the underlying mechanisms are unknown.
To systematically map out the components of the overfed state, the investigators will execute a 2-week randomized controlled overfeeding trial in lean and overweight individuals. The trial is preceded by a 1-week lead-in period and followed by a 2-wk controlled ad libitum study period. The comparison between lean and overweight subjects, men and women, enables the determination of whether a differential response in overfeeding-induced signals is present in relation to BMI and sex.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Christoffer Clemmensen, Assoc. Prof.
- Phone Number: +45 22 91 63 33
- Email: chc@sund.ku.dk
Study Locations
-
-
Norrebro
-
Copenhagen, Norrebro, Denmark, 2200
- University of Copenhagen
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Male or female otherwise healthy subjects
- 20-40 years of age
- BMI (Body mass index) between 22-30 kg/m2
Exclusion Criteria:
- Present or previous cardiovascular disease, diabetes or thyroid-disease
- smoking
- more than 3 hours of planned physical activity per week
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Control group
Subjects in this group will have a daily energy intake equivalent of 100 % of their calculated normal daily energy intake.
|
Two weeks of isocaloric weight maintenance
|
Experimental: Overfed group
Subjects in this group will have a daily energy intake equivalent of 150 % of their calculated normal daily energy intake.
|
Two weeks of overfeeding
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in blood protein patterns using proteomics 1 week before, during 2 weeks of overfeeding and 2 weeks after overfeeding
Time Frame: 5 weeks
|
Blood will be collected for proteomics at screening, at baseline, during the overfeeding intervention and during the 2-week ad libitum intervention.
Samples will be measured using LCMS instrumentation consisting of a nanoelectrospray ion source to a Q Exactive HF mass spectrometer.
|
5 weeks
|
Changes in blood peptide patterns using peptidomics 1 week before, during 2 weeks of overfeeding and 2 weeks after overfeeding
Time Frame: 5 weeks
|
Blood will be collected for peptidomics at screening, at baseline, during the overfeeding intervention and during the 2-week ad libitum intervention.
Samples will be measured using LCMS instrumentation consisting of a nanoelectrospray ion source to a Q Exactive HF mass spectrometer.
|
5 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Body weight
Time Frame: 5 weeks
|
Body weight will be measured (in kilograms) daily during the intervention using electronic Fitbit Aria 2 weight scale.
|
5 weeks
|
Fat biopsy from subcutaneous adipose tissue before and after 2 weeks of overfeeding
Time Frame: 2 weeks
|
Fat biopsies are obtained using Bergström biopsy needle from subcutaneous adipose tissue in the abdominal region before and after 14 days of overfeeding to assess regulated enzymes and proteins.
|
2 weeks
|
Microdialysate from subcutaneous adipose tissue before and after 2 weeks of overfeeding. The samples will be used for detection of known and unknown secreted factors
Time Frame: 2 weeks
|
Microdialysates are collected from micro dialysis catheters inserted into the subcutaneous adipose tissue in the abdominal region before and after 14 days of overfeeding to assess regulated enzymes and proteins.
|
2 weeks
|
Body composition in 40 subjects before and after overfeeding
Time Frame: 3 weeks
|
Body composition will be measured using Dual-Energy X-ray Absorptiometry (DXA) at screening (1 week before baseline), at baseline and after 14 days of overfeeding.
The DXA scan enables the detection of body lean mass and body fat mass in kg.
|
3 weeks
|
Mixed meal test
Time Frame: 2 weeks
|
Before and after the intervention a mixed meal test will be performed
|
2 weeks
|
Changes in blood metabolome 1 week before, during 2 weeks of overfeeding and 2 weeks after overfeeding
Time Frame: 5 weeks
|
Blood will be collected for metabolomics at screening, at baseline, during the overfeeding intervention and during the 2-week ad libitum intervention.
Metabolomics will be performed using Mass Spectrometry.
|
5 weeks
|
Activity profile of 40 subjects during the 5 week study period
Time Frame: 5 weeks
|
Assessment of daily physical activity levels (wearables and doubly-labelled water)
|
5 weeks
|
Detection of circulating factors
Time Frame: 5 weeks
|
The investigators will measure the concentration of known circulating factors from fasted blood samples and from blood samples obtained during mixed meal test, such as: Glucose, insulin, hsCRP, Hba1c, cortisol, ACTH, lactate, fatty acids, triglycerides, glycerol, catecholamines, leptin, ghrelin, adiponectin, glucagon, GDF15, FGF21, FGF19, GIP, GLP-1, PYY, CCK, interleukins, cytokines, tissue-kines, T3, T4, TSH, cholesterol.
|
5 weeks
|
Gut microbiome profile before and after 14 days of overfeeding
Time Frame: 2 weeks
|
Feces samples will be collected before and after 14 days of overfeeding and microbiome composition will be analyzed by using UPLC-MS/GC-MS.
|
2 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Christoffer Clemmensen, Assoc. Prof., Assoc. prof. NNF Center for Basic Metabolic Research
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- ExpO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Fundació Sant Joan de DéuRecruitingObesity, Childhood | Obesity, AdolescentSpain
-
Consorcio Centro de Investigación Biomédica en...Maimónides Biomedical Research Institute of Córdoba; Instituto de Salud Carlos... and other collaboratorsActive, not recruiting
-
University of HoustonBaylor College of MedicineCompleted
Clinical Trials on Isocaloric diet
-
German Institute of Human NutritionCharite University, Berlin, Germany; University of Southern California; German... and other collaboratorsCompleted
-
Clinique Romande de ReadaptationCompletedPhysical Activity | Ketogenic Dieting | Altitude HypoxiaSwitzerland
-
University of CopenhagenDeakin University; Monash HealthCompletedOvernutrition | Fertility Issues | Nutrition, Healthy | Epigenetic DisorderDenmark
-
Laval UniversityDairy Farmers of Canada; Dairy Australia; Institute of Nutraceuticals and Functional...CompletedCardiovascular DiseaseCanada
-
Universitaire Ziekenhuizen KU LeuvenRecruitingLymphedema | Ketogenic DietingBelgium
-
Laval UniversityCanadian Institutes of Health Research (CIHR)Completed
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompleted
-
Thai Otsuka Pharmaceutical Co., Ltd.Completed
-
Meropi KontogianniNational and Kapodistrian University of Athens; Agricultural University of...CompletedHyperglycemia | Hyperinsulinism | Impaired Glucose Tolerance | Insulin Sensitivity | Poor Glycemic Control
-
Tufts UniversityNational Pecan Shellers AssociationCompletedCardiovascular Disease Risk | Type 2 Diabetes RiskUnited States